Searching for Solutions

No summary available

Use of GLP-1 receptor agonists was consistently associated with reduced risks of developing various incident SUDs, suggesting a broad preventive effect across multiple substance types.

AAPP President Jolene Bostwick talks about the future and our new strategic plan.

This blog series by the Resident and New Practitioner Committee is targeted to psychiatric pharmacists seeking their first or a new position. This blog explores opportunities in the pharmaceutical industry.

AAPP joined the Advanced Professional Workforce Alliance (APWA) and other organizations to comment on the Reimagining and Improving Student Education (RISE) Notice of Proposed Rulemaking (NPRM). The letter expresses concerns regarding the proposed definition of “professional degrees” in relation to other graduate degree programs. The concern is that the proposed framework and definition of “professional degrees” does not encompass the range of programs that fit the professional designation.

Last fall, Washington and other Western states issued their own vaccine recommendations in a sharp rejection of federal policy that Health Secretary Robert F. Kennedy Jr. has upended. And on Thursday, the Washington Legislature passed legislation to change state law so that vaccine coverage is tied to recommendations from the state, not a federal panel filled with Kennedy appointees.

Kennedy has continued to spread misinformation and push politicised agendas at the expense of the country’s most vulnerable.

In our newest member profile showcasing psychiatric pharmacist impact, learn how Dr. Kesoma Holcomb worked with her health system to create an opioid and psychotropic stewardship program that continues to optimize medication therapy for high-risk and clinically complex patients who are medically ill and have co-occurring mental health and chronic pain conditions.

AAPP's newest member profile showcases psychiatric pharmacist impact through a psychotropic stewardship program demonstrating optimization of medication therapy for high-risk and clinically complex patients.

The toolkit outlines strategies for promoting early identification and intervention, improving access through service coordination and integration, and building workforce capacity to meet children’s behavioral health needs. It also provides an overview of key behavioral health services and models of care, along with resources to support state implementation of EPSDT requirements.

NAMI has worked with experts to create 23 flexible lessons about mental health literacy for middle school classrooms. Supporting early intervention is one of the best ways to address the youth mental health crisis. Learn more and ask your local schools to add mental health literacy to their curriculum.

A randomized clinical trial of 59 male participants with opioid use disorder found that those receiving 10 supervised yoga sessions over 14 days alongside standard buprenorphine treatment had achieved withdrawal stabilization 4.4 times faster than controls, with median stabilization occurring in five days compared to nine.

A study that surveyed college students tested whether alcohol and cannabis co-use and cannabis use characteristics (frequency and quantity) relate to different levels of heavy drinking. Heavy drinking was more common on co-use days than alcohol-only days (33% higher odds of heavy episodic and 52% higher odds of high-intensity vs. moderate).

A research summary from the Recovery Research Institute highlights a Phase 2 randomized clinical trial testing the efficacy of heart rate variability biofeedback, a breathing-based intervention, in reducing stress-related craving and substance use among people in remission.

A majority of participants supported psychedelics as a treatment and would accept receiving psychedelics as a treatment.

New research published in JAMA Network Open found a correlation between China’s crackdowns on illicit fentanyl precursor chemicals and the recent decline in U.S. overdose deaths, suggesting that Chinese regulatory enforcement may have disrupted the supply chain driving the opioid crisis.

In this survey study of clinician-reported problems initiating BUP treatment, clinicians working in high-volume noninpatient settings reported more problems initiating BUP in patients using fentanyl, and many reported changing their clinical practices in response to these problems.

Through this Consensus Statement, the Task Force identified circumstances in which the selective elimination of certain psychotropic medications may be clinically indicated.

The Brookings Institution released a white paper examining how the Drug Enforcement Administration’s quota and inventory controls impact certain drug shortages.